FIGURE 5.
Sample sizes required to detect the desired minimum clinically important difference across the range of values on the x-axis (A) a change in one-year mean HbA1c from 7% (e.g., a reduction from 7% to 6.5% would require 65 patients per group) and (B) a relative risk reduction in graft loss from 20% at 1 year (e.g., a reduction from 20% to 16% would require 1,444 patients per group).
